论文部分内容阅读
卵巢癌的复发和耐药是治疗的重点和难点。目前 ,仍没有较为可靠的治疗手段 ,多周期、大剂量化疗辅以外周血干细胞回输支持 ,作为复发或难治性卵巢癌的巩固或一线治疗方案 ,则能够明显减少大剂量化疗引起的毒副反应 ,缩短化疗周期 ,国外已进行了多中心、多周期、多方案的临床探索 ,有望成为治疗此类卵巢癌的有效方案。
Ovarian cancer recurrence and resistance is the treatment of the key and difficult. At present, there is still no reliable treatment, multi-cycle, high-dose chemotherapy combined with peripheral blood stem cell infusion support, as a solid or first-line treatment of recurrent or refractory ovarian cancer, can significantly reduce the high dose chemotherapy-induced toxicity Side effects, shorten the cycle of chemotherapy, foreign countries have conducted a multi-center, multi-cycle, multi-program clinical exploration, is expected to become an effective treatment of such ovarian cancer programs.